Preclinical and clinical studies rigorously examine their anti-inflammatory effects, highlighting significant benefits in these conditions
Complex carbohydrates like oatmeal, brown rice, sweet potatoes, and quinoa can be tolerated well by most GLP-1 users, especially when paired with protein
SGLT2i use is associated with an increased risk of DKA and UTI, but confers several favourable outcomes, notably preservation of renal function, reduced risk of developing heart failure and CKD, and of hospitalisation, despite a higher prevalence of heart failure, hypertension, IHD and CKD at baseline
Observational analyses and randomized clinical trials consistently report nausea, vomiting, diarrhea, constipation, and abdominal discomfort as the most common symptoms, although the distribution of events varies
Standardized uptake value (SUV) was calculated [SUV = radioactivity activity concentration (KBq/ml)/body weight (g)/injected dose (kBq)] for semi-quantitative analysis